Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Artery Disease or Myocardial Ischemia
and you are
between 18 and 84
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the safety and performance of a new version of a coronary artery stent for treating blockages in the arteries supplying blood to the heart muscle. The Amaranth Medical MAGNITUDE scaffold releases a drug (sirolimus) to reduce the likelihood of the treated blood vessel developing a new blockage. In addition, the scaffold dissolves away over time, leaving no permanent implant after the blood vessel has healed.

Provided treatments

  • Device: AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02900937. The sponsor of the trial is Amaranth Medical Inc. and it is looking for 70 volunteers for the current phase.
Official trial title:
Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial III